Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation

Endocrinology

Volumn 146, Issue 12, 2005, Pages 5128-5134

  Boelen, A ^a,c   Kwakkel, J ^a   Alkemade, A ^a   Renckens, R ^a   Kaptein, E ^b   Kuiper, G ^b   Wiersinga, W M ^a   Visser, T J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; ENZYME; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIOTHYRONINE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 8; THYROID HORMONE; TURPENTINE; TYPE 1 DEIODINASE; TYPE 3 DEIODINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; IMMUNOREACTIVITY; INFLAMMATORY CELL; LIVER; MOUSE; MUSCLE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SUBCUTANEOUS TISSUE;

ABSCESS; ANIMALS; CHRONIC DISEASE; FEMALE; HINDLIMB; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1; INTERLEUKIN-6; IODIDE PEROXIDASE; IRRITANTS; LIPOPOLYSACCHARIDES; LIVER; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DISEASES; RNA, MESSENGER; SUBCUTANEOUS TISSUE; TURPENTINE;

EID: 27844524943     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0608     Document Type: Article

References (34)

1. Kohrle J 1999 Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151:103-119
2. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
3. Wiersinga WM 2000 Nonthyroidal illness. In: Braverman LE, Utiger RD, eds. The thyroid. Philadelphia: Lippincott; 281-295
4. Peeters RP, Wouters PJ, Kaptein E, Van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-3211
5. Wassen FW, Schiel AE, Kuiper GG, Kaptein E, Bakker O, Visser TJ, Simonides WS 2002 Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143:2812-2815
6. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM 1996 Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology 137:5250-5254
7. 2). Methods Enzymol 84:272-303
8. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, Trajkovic V, Campbell CC, Xu D, Liew FY 2001 A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 166:6633-6639
9. Bouaboula M, Legoux P, Pessegue B, Delpech B, Dumont X, Piechaczyk M, Casellas P, Shire D 1992 Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 267:21830-21838
10. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM 2004 Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 182:315-323
11. Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Baur A, Kohrle J, Wiersinga WM 2004 Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness. Horm Metab Res 36:101-106
12. Kuiper GG, Klootwijk W, Visser TJ 2003 Substitution of cysteine for seleno-cysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Endocrinology 144:2505-2513
13. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135
14. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ, Fliers E 2005 Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab 90:4322-4334
15. Hora SCW 1984 The F-statistic in two-way layout with rank-scored transformed data. J Am Stat Assoc 79:668-673
16. Ramadori G, Christ B 1999 Cytokines and the hepatic acute-phase response. Semin Liver Dis 19:141-155
17. Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H 2000 A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106:393-402
18. 3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 275:38296-38301
19. Leon LR 2002 Invited review: cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 92:2648-2655
20. Lohrer P, Gloddek J, Nagashima AC, Korali Z, Hopfner U, Pereda MP, Arzt E, Stalla GK, Renner U 2000 Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 141:4457-4465
21. Zandieh Doulabi B, Platvoet-ter Schiphorst M, Kalsbeek A, Fliers E, Bakker O, Wiersinga WM 2004 Diurnal variation in rat liver thyroid hormone receptor (TR)-α messenger ribonucleic acid (mRNA) is dependent on the biological clock in the suprachiasmatic nucleus, whereas diurnal variation of TR β1 mRNA is modified by food intake. Endocrinology 145:1284-1289
22. Kalsbeek A, Buijs RM, van Schaik R, Kaptein E, Visser TJ, Zandieh Doulabi B, Fliers E 2005 Daily variations in type II iodothyronine deiodinase activity in the rat brain as controlled by the biological clock. Endocrinology 146:1418-1427
23. Hernandez A, St. Germain DL, Obregon MJ 1998 Transcriptional activation of type III inner ring deiodinase by growth factors in cultured rat brown adipocytes. Endocrinology 139:634-639
24. Pallud S, Ramauge M, Gavaret JM, Lennon AM, Munsch N, St. Germain DL, Pierre M, Courtin F 1999 Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology 140:2917-2923
25. Huang SA, Fish SA, Dorfman DM, Salvatore D, Kozakewich HP, Mandel SJ, Larsen PR 2002 A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab 87:4457-4461
26. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, Fishman SJ, Larsen PR 2000 Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185-189
27. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
28. Song KS, Seong JK, Chung KC, Lee WJ, Kim CH, Cho KN, Kang CD, Koo JS, Yoon JH 2003 Induction of MUC8 gene expression by interleukin-1β is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells. J Biol Chem 278:34890-34896
29. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N 2001 Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429-1439
30. Suzuki K, Hino M, Kutsuna H, Hato F, Sakamoto C, Takahashi T, Tatsumi N, Kitagawa S 2001 Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1β. J Immunol 167:5940-5947
31. Kumar A, Middleton A, Chambers TC, Mehta KD 1998 Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 273:15742-15748
32. O'Mara BA, Dittrich W, Lauterio TJ, St. Germain DL 1993 Pretranslational regulation of type I 5′-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology 133:1715-1723
33. Boelen A, Platvoet-ter Schiphorst MC, van Rooijen N, Wiersinga WM 1996 Selective macrophage depletion in the liver does not prevent the development of the sick euthyroid syndrome in the mouse. Eur J Endocrinol 134:513-518
34. Maglich JM, Watson J, McMillen PJ, Goodwin B, Willson TM, Moore JT 2004 The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem 279:19832-19838